Literature DB >> 31462725

Historical changes and between-facility differences in adrenal venous sampling for primary aldosteronism in Japan.

Yuichi Fujii1, Yoshiyu Takeda2, Isao Kurihara3, Hiroshi Itoh3, Takuyuki Katabami4, Takamasa Ichijo5, Norio Wada6, Yui Shibayama6, Takanobu Yoshimoto7, Yoshihiro Ogawa7,8, Junji Kawashima9, Masakatsu Sone10, Nobuya Inagaki10, Katsutoshi Takahashi11,12, Minemori Watanabe13, Yuichi Matsuda14, Hiroki Kobayashi15, Hirotaka Shibata16, Kohei Kamemura17, Michio Otsuki18, Koichi Yamamto19, Atsushi Ogo20, Toshihiko Yanase21, Shintaro Okamura22, Shozo Miyauchi23, Megumi Fujita24, Tomoko Suzuki25, Hironobu Umakoshi26, Tatsuki Ogasawara26, Mika Tsuiki26, Mitsuhide Naruse26,27.   

Abstract

Primary aldosteronism (PA) is a common curable cause of hypertension. Adrenal venous sampling (AVS) is recommended for subtype diagnosis but is a difficult procedure. Recently, an increased prevalence of PA was reported, creating a greater demand for treatment of the condition in clinical facilities. The aim of the present study was to identify the historical changes over time and the differences between facilities in the success rate and subtype diagnosis of PA. The database of the PA registry developed by the Japan PA Study (JPAS) was used. A total of 2599 patients with PA who underwent AVS were evaluated. The overall success rate of AVS was 88%. The bilateral subtype was the dominant subtype, comprising 69% of cases. During the period 2004-2011 to 2011-2017, there were significant changes in the total number of AVS procedures (from 562 to 1732), ratio of ACTH administration with AVS (75 to 97%), success rate (79 to 90%), and proportion with bilateral subtype diagnosis (53 to 72%). There were also significant inter-facility differences in the number of AVS procedures (6 to 322), success rate (59 to 97%), and proportion with the bilateral subtype (44 to 86%). The principal enrolled department was Endocrinology (86%), and the ratio of unilateral PA was significantly higher in this department than in others (32% vs. 25%). In conclusion, the number of AVS procedures performed, the success rate, and the proportion with the bilateral subtype increased over time after normalizing the centre difference. Significant differences were observed between the centres.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31462725     DOI: 10.1038/s41371-019-0229-4

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  29 in total

Review 1.  Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension.

Authors:  Pierre-François Plouin; Laurence Amar; Gilles Chatellier
Journal:  Nephrol Dial Transplant       Date:  2004-04       Impact factor: 5.992

2.  Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism.

Authors:  Masao Omura; Hironobu Sasano; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2006-11       Impact factor: 3.872

3.  Subtype prediction of primary aldosteronism by combining aldosterone concentrations in the left adrenal vein and inferior vena cava: a multicenter collaborative study on adrenal venous sampling.

Authors:  Yuichi Fujii; Hironobu Umakoshi; Norio Wada; Takamasa Ichijo; Kohei Kamemura; Yuichi Matsuda; Tatsuya Kai; Tomikazu Fukuoka; Ryuichi Sakamoto; Atsushi Ogo; Tomoko Suzuki; Kazutaka Nanba; Mika Tsuiki; Mitsuhide Naruse
Journal:  J Hum Hypertens       Date:  2017-11-24       Impact factor: 3.012

4.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.

Authors:  Paul Milliez; Xavier Girerd; Pierre-François Plouin; Jacques Blacher; Michel E Safar; Jean-Jacques Mourad
Journal:  J Am Coll Cardiol       Date:  2005-04-19       Impact factor: 24.094

Review 5.  Prevalence of primary aldosteronism in patient's cohorts and in population-based studies--a review of the current literature.

Authors:  A Hannemann; H Wallaschofski
Journal:  Horm Metab Res       Date:  2011-12-01       Impact factor: 2.936

6.  Significance of Computed Tomography and Serum Potassium in Predicting Subtype Diagnosis of Primary Aldosteronism.

Authors:  Hironobu Umakoshi; Mika Tsuiki; Yoshiyu Takeda; Isao Kurihara; Hiroshi Itoh; Takuyuki Katabami; Takamasa Ichijo; Norio Wada; Takanobu Yoshimoto; Yoshihiro Ogawa; Junji Kawashima; Masakatsu Sone; Nobuya Inagaki; Katsutoshi Takahashi; Minemori Watanabe; Yuichi Matsuda; Hiroki Kobayashi; Hirotaka Shibata; Kohei Kamemura; Michio Otsuki; Yuichi Fujii; Koichi Yamamto; Atsushi Ogo; Toshihiko Yanase; Tomoko Suzuki; Mitsuhide Naruse
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

7.  Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.

Authors:  Paolo Mulatero; Michael Stowasser; Keh-Chuan Loh; Carlos E Fardella; Richard D Gordon; Lorena Mosso; Celso E Gomez-Sanchez; Franco Veglio; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2004-03       Impact factor: 5.958

Review 8.  Minireview: primary aldosteronism--changing concepts in diagnosis and treatment.

Authors:  William F Young
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

9.  What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?

Authors:  William F Young; Anthony W Stanson
Journal:  Clin Endocrinol (Oxf)       Date:  2009-01       Impact factor: 3.478

10.  An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism.

Authors:  Gian Paolo Rossi; Richard J Auchus; Morris Brown; Jacques W M Lenders; Mitsuhide Naruse; Pierre Francois Plouin; Fumitoshi Satoh; William F Young
Journal:  Hypertension       Date:  2013-11-11       Impact factor: 10.190

View more
  2 in total

1.  Primary aldosteronism due to bilateral micronodular hyperplasia and concomitant subclinical Cushing's syndrome: A case report.

Authors:  Hiroki Teragawa; Chikage Oshita; Yuichi Orita; Kunihiro Hashimoto; Hirofumi Nakayama; Yuto Yamazaki; Hironobu Sasano
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

2.  Should Adrenal Venous Sampling Be Performed in PA Patients Without Apparent Adrenal Tumors?

Authors:  Kentaro Okamoto; Youichi Ohno; Masakatsu Sone; Nobuya Inagaki; Takamasa Ichijo; Takashi Yoneda; Mika Tsuiki; Norio Wada; Kenji Oki; Kouichi Tamura; Hiroki Kobayashi; Shoichiro Izawa; Akiyo Tanabe; Mitsuhide Naruse
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.